Published on in Vol 24, No 1 (2022): January
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/24126, first published
.
Journals
- Alibudbud R. Expanding Pre-Exposure Prophylaxis (PrEP) Utilization in the Philippine HIV Crisis. Journal of Primary Care & Community Health 2023;14 View
- Shan D, Xue H, Yu F, Zan X, Liu H, Liu J, Han M, Zhang D. Understanding the Uptake and Outcomes of Non-occupational Postexposure Prophylaxis Use Through an Online Medical Platform in China: Web-Based Cross-sectional Study. Journal of Medical Internet Research 2023;25:e42729 View
- Chen S, Ruan Y, Liu L, Pei H, Jiang Y, Huang T, Wei Y, Qin L, Dai X, Liu Y, Liu J, Xie Y. Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China. Frontiers in Pharmacology 2024;15 View
- Espera J, Reyes C, Sarmiento E, Sitchon C, Zantua R, Carandang R. Acceptability and feasibility of HIV pre-exposure prophylaxis (PrEP) in Southeast Asia: A scoping review. International Journal of STD & AIDS 2025;36(4):260 View
- Gabucan V. Cross-sectional study measuring the level and relationship of awareness, attitude and willingness to use HIV pre-exposure prophylaxis in Davao City, Philippines. BMJ Open 2025;15(1):e091977 View
- Pamoso A, Rasmussen M, Sutarsa I, Scholz B, Montague-Cardoso K. The whole is greater than the sum of its parts: Integrating syndemics and intersectionality in tackling the HIV and mental health epidemics among Filipino gay and bisexual men. PLOS Mental Health 2025;2(2):e0000252 View